Quantcast

First 100% Bioavailable Resveratrol Supplement from Phase4 Pharmaceutical

February 19, 2014

February 2014 – Phase4 Pharmaceutical – AgeForce® Division introduces the first 100% bioavailable resveratrol supplement in a transdermal time-release patch.

HALLANDALE BEACH, Fla., Feb. 19, 2014 /PRNewswire-iReach/ — The Problem: Less than 1% of any orally ingested resveratrol supplement survives digestive stomach acid, intestinal bacteria, and first-pass liver functions, before entering the bloodstream.

The Solution: According to the company’s CEO Steve Lapidus: “We needed to bypass the digestive system and the liver to deliver a clinically effective dosage of resveratrol to one’s bloodstream. To accomplish this we developed, and are now marketing via our website a transdermal time-release patch that delivers a 75mg dose of trans-resveratrol directly to one’s bloodstream. Bioavailability with our patch is 100% as compared to 1% when take orally! A person would have to ingest 7,500mg at a minimum orally to get the equivalent dosage of our transdermal time-release patch into their bloodstream! This is the first time that the health & fitness conscience consumer can effectively get the proven benefits of this remarkable substance!”

There are many clinical trials and peer review studies that support the benefits of trans-resveratrol to include:

    --  Longevity
    --  Obesity
    --  Powerful Antioxidant
    --  Elevates Energy & Endurance
    --  May Help To Prevent Certain Cancers & Cure
    --  Reduced Risk Of Heart Disease
    --  Anti Diabetic Effects
    --  Skin Protection
    --  May Help To Protect Against Alzheimer's Disease and Huntington's Disease
    --  Anti-Inflammatory
    --  Antiviral (herpes simplex virus and others)
    --  Elevates Testosterone Levels
    --  Opioid Tolerance Reduction

About: Phase4 Pharmaceutical – AgeForce® Division develops and sells health and fitness supplements featuring transdermal time-release direct to bloodstream delivery worldwide. To assure pharmaceutical efficacy and quality, the company formulates and manufactures all of their supplements exclusively in the United States.

Bioavailability Barriers Of Resveratrol – Wikipedia – Resveratrol Bioavailability Of Resveratrol N.Y. Acad. Sci. ISSN 0077-8923

Media Contact: Stephen Lapidus, Phase4 Pharmaceutical, 305 788 6604, spiderlap@gmail.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Phase4 Pharmaceutical


Source: PR Newswire



comments powered by Disqus